234 related articles for article (PubMed ID: 31367795)
1. Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
Gilboa M; Bornstein G; Ben-Zvi I; Grossman C
Rheumatol Int; 2020 Apr; 40(4):663-669. PubMed ID: 31367795
[TBL] [Abstract][Full Text] [Related]
2. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
[TBL] [Abstract][Full Text] [Related]
6. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
[TBL] [Abstract][Full Text] [Related]
7. The incidence of macrophage activation syndrome in children with rheumatic disorders.
Moradinejad MH; Ziaee V
Minerva Pediatr; 2011 Dec; 63(6):459-66. PubMed ID: 22075800
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of macrophage activation syndrome in the adult northern Chinese population.
Li X; Qu B; Nie Y; Zhu G; Li W; Mu F
Lupus; 2014 Jul; 23(8):785-92. PubMed ID: 24682586
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and treatment outcomes of macrophage activation syndrome in adults: A case series of 67 patients].
Yao HH; Wang YN; Zhang X; Zhao JX; Jia Y; Wang Z; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):996-1002. PubMed ID: 31848493
[TBL] [Abstract][Full Text] [Related]
10. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
Huang S; Liu Y; Yan W; Zhang T; Wang P; Zhu M; Zhang X; Zhou P; Fan Z; Yu H
Pediatr Rheumatol Online J; 2024 May; 22(1):58. PubMed ID: 38783316
[TBL] [Abstract][Full Text] [Related]
11. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract][Full Text] [Related]
12. Macrophage Activation Syndrome in Paediatric Rheumatic Diseases.
Islam MI; Talukder MK; Islam MM; Laila K; Rahman SA
Mymensingh Med J; 2017 Apr; 26(2):356-363. PubMed ID: 28588173
[TBL] [Abstract][Full Text] [Related]
13. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
Ruscitti P; Rago C; Breda L; Cipriani P; Liakouli V; Berardicurti O; Carubbi F; Di Battista C; Verrotti A; Giacomelli R
Clin Rheumatol; 2017 Dec; 36(12):2839-2845. PubMed ID: 28914368
[TBL] [Abstract][Full Text] [Related]
14. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
[TBL] [Abstract][Full Text] [Related]
15. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome.
Inoue N; Schulert GS
Arthritis Res Ther; 2023 Mar; 25(1):48. PubMed ID: 36964620
[TBL] [Abstract][Full Text] [Related]
16. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
[No Abstract] [Full Text] [Related]
17. Evaluation of macrophage activation syndrome in hospitalised patients with Kikuchi-Fujimoto disease based on the 2016 EULAR/ACR/PRINTO classification criteria.
Ahn SS; Lee B; Kim D; Jung SM; Lee SW; Park MC; Park YB; Hwang YG; Song JJ
PLoS One; 2019; 14(7):e0219970. PubMed ID: 31318961
[TBL] [Abstract][Full Text] [Related]
18. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
19. Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature.
Sönmez HE; Demir S; Bilginer Y; Özen S
Clin Rheumatol; 2018 Dec; 37(12):3329-3335. PubMed ID: 29663156
[TBL] [Abstract][Full Text] [Related]
20. Macrophage Activation Syndrome (MAS): A Case Report and Narrative Review.
Dilibe A; Ugoala OS; Evbayekha EO; Khalilullah MZ; Adabale OK; Poyser TA; Oriaifo OF; Olori UI; Aiwuyo HO
Cureus; 2023 Mar; 15(3):e35670. PubMed ID: 37012949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]